EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Intravitreal adenine base editing of RS1 improves vision in a preclinical mouse model of retinoschisis

Dong Hyun Jo, Hyewon Jang, Chang Sik Cho, Seok Jae Lee, Ji Hwa Heo, Jung Ah Kim, Se Jin Kim, WonHyoung Ryu, Chan-Wook Park, Byeong-Cheol Kang, Heon Yung Gee, Young Hoon Sung und 2 weitere

Molecular Therapy · 2025

DOI: 10.1016/j.ymthe.2025.04.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2025. Verfasst von Dong Hyun Jo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Global Excellence Center for G…. Hauptthemen laut MEDLINE: Gene Editing, Retinoschisis, Adenine, Eye Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Seoul National University Hospital, National Research Council of Science and Technology, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Base editing offers high potential for treating genetic diseases, particularly those with limited treatment options. Retinoschisis, an X-linked retinal disease causing progressive vision loss, currently lacks effective therapies. We identified the c.422G>A (p.Arg141His) variant of the RS1 gene in six male patients with retinoschisis and generated a humanized mouse model harboring this variant, which mimicked the disease phenotype. By testing adenine base editors and single-guide RNAs, we identified an optimal combination of high editing efficiency and low bystander editing. Intravitreal injection of adeno-associated viral vectors encoding this adenine base editor achieved ∼40% editing efficiency in all retinal cells, restored retinal layer integrity, and preserved visual functions in 2-week-old male hemizygous mice. These mice exhibited retinal layer splitting at baseline, further validating the model. This study demonstrates a strategy for identifying effective base editing tools for clinical use through the preclinical evaluation of humanized mouse lines with patient-derived mutations and highlights their applicability in treating genetic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingRetinoschisisAdenineEye ProteinsVision, OcularAnimalsMiceDisease Models, AnimalHumansMaleDependovirusGenetic TherapyGenetic VectorsRetinaIntravitreal InjectionsRNA, Guide, CRISPR-Cas Systems

Stichwörter der Autor:innen

RS1adenine base editingadeno-associated virusintravitreal injectionretinaretinitis

Substanzen

AdenineRS1 protein, humanEye ProteinsRNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Department of Anatomy and Cell Biology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Global Excellence Center for Gene & Cell Therapy (GEC-GCT), Seoul National University Hospital, Seou…
  • Department of Pharmacology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • Fight Against Angiogenesis-Related Blindness (FARB) Laboratory, Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, Republic of Korea.
  • Department of Cell and Genetic Engineering and Convergence Medicine Research Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul 03080, Republic of Korea.
  • Department of Pharmacology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Republic…
  • School of Mechanical Engineering, Yonsei University, Seoul 03722, Republic of Korea.

Förderung

  • Seoul National University Hospital
  • National Research Council of Science and Technology
  • National Research Foundation of Korea
  • Yonsei University College of Medicine
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Jo, D. H., Jang, H., Cho, C. S., Lee, S. J., Heo, J. H., Kim, J. A., Kim, S. J., Ryu, W., Park, C. W., Kang, B. C., Gee, H. Y., Sung, Y. H., Kim, H. H., & Kim, J. H. (2025). Intravitreal adenine base editing of RS1 improves vision in a preclinical mouse model of retinoschisis. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.04.021

Vancouver

Jo DH, Jang H, Cho CS, Lee SJ, Heo JH, Kim JA, et al. Intravitreal adenine base editing of RS1 improves vision in a preclinical mouse model of retinoschisis. Molecular Therapy. 2025. doi:10.1016/j.ymthe.2025.04.021

BibTeX
@article{Jo2025,
  author = {Jo, Dong Hyun and Jang, Hyewon and Cho, Chang Sik and Lee, Seok Jae and Heo, Ji Hwa and Kim, Jung Ah and Kim, Se Jin and Ryu, WonHyoung and Park, Chan-Wook and Kang, Byeong-Cheol and Gee, Heon Yung and Sung, Young Hoon and Kim, Hyongbum Henry and Kim, Jeong Hun},
  title = {Intravitreal adenine base editing of RS1 improves vision in a preclinical mouse model of retinoschisis},
  journal = {Molecular Therapy},
  year = {2025},
  doi = {10.1016/j.ymthe.2025.04.021}
}
Kostenlos starten →